Profund Advisors LLC purchased a new stake in shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Free Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 39,316 shares of the biotechnology company’s stock, valued at approximately $959,000. Other hedge funds and other institutional […]